Rivaroxaban

Details

Files
Generic Name:
Rivaroxaban
Project Status:
Complete
Therapeutic Area:
Atrial fibrillation, stroke prevention
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Xarelto
Project Line:
Reimbursement Review
Project Number:
SR0257-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Atrial fibrillation, stroke prevention
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: